Tech Company Financing Transactions

Fusion Pharmaceuticals Funding Round

Fusion Pharmaceuticals closed a $105 million Series B funding round on 4/3/2019. Investors included OrbiMed, Varian Medical Systems and Adams Street Partners.

Transaction Overview

Company Name
Fusion Pharmaceuticals
Announced On
4/3/2019
Transaction Type
Venture Equity
Amount
$105,000,000
Round
Series B
Investors

OrbiMed (Lead Investor) (Chau Khuong)

Varian Medical Systems (Lead Investor) (Deepak Khuntia)

Adams Street Partners (Terry Gould)

FACIT

Genesys Capital

Healthcap Venture Capital

Johnson & Johnson Development Corporation (Asish Xavier)

Perceptive Advisors

Pivotal bioVenture Partners

Rock Springs Capital

Seroba Life Sciences (Alan O'Connell)

TPG Biotech

Proceeds Purpose
The financing will be used to advance and broaden the scope of Fusion's ongoing clinical program in targeted alpha therapeutics, and accelerate a pipeline of new radiopharmaceuticals and combination therapy strategies.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
451 D St. 930
Boston, MA 02110
USA
Phone
(617) 420-5698
Website
www.fusionpharma.com
Email Address
[email protected]
Overview
Fusion Pharmaceuticals is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre.
Profile
Fusion Pharmaceuticals LinkedIn Company Profile
Social Media
Fusion Pharmaceuticals Company Twitter Account
Company News
Fusion Pharmaceuticals News
Facebook
Fusion Pharmaceuticals on Facebook
YouTube
Fusion Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Valliant
  John Valliant LinkedIn Profile  John Valliant Twitter Account  John Valliant News  John Valliant on Facebook
Chief Financial Officer
John Crowley
  John Crowley LinkedIn Profile  John Crowley Twitter Account  John Crowley News  John Crowley on Facebook
Chief Scientific Officer
Eric Burak
  Eric Burak LinkedIn Profile  Eric Burak Twitter Account  Eric Burak News  Eric Burak on Facebook
VP - Bus. Development
Marc Schwabish
  Marc Schwabish LinkedIn Profile  Marc Schwabish Twitter Account  Marc Schwabish News  Marc Schwabish on Facebook
VP - Finance
Lynn Wick
  Lynn Wick LinkedIn Profile  Lynn Wick Twitter Account  Lynn Wick News  Lynn Wick on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/3/2019: Green Tank Technologies venture capital transaction
Next: 4/3/2019: Blueprint Health IT venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.